One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
  • [email protected]
  • +1 718 874 1545 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
Home ➤ Life Science ➤ Pharmaceuticals ➤ Animal Model Market
Animal Model Market
Animal Model Market
Published date: Animal Model Market • Formats:
Request Sample Schedule a Call
  • Home ➤ Life Science ➤ Pharmaceuticals ➤ Animal Model Market

Global Animal Model Market By Animal Type (Mice, Rat, Guinea Pigs, and Others), By Application (Cancer, Immunological Disease, Infectious Disease, and Others), By End-user (Pharmaceutical & Biotechnology Companies, Academic Research Institute, and Contract Research Organization), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

  • Published date: Animal Model Market
  • Report ID: 146082
  • Number of Pages: 269
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Free Sample
  • Quick Navigation

    • Report Overview
    • Key Takeaways
    • Animal Type Analysis
    • Application Analysis
    • End-User Analysis
    • Key Market Segments
    • Drivers
    • Restraints
    • Opportunities
    • Impact of Macroeconomic / Geopolitical Factors
    • Latest Trends
    • Regional Analysis
    • Key Players Analysis
    • Recent Developments
    • Report Scope

    Report Overview

    Global Animal Model Market size is expected to be worth around US$ 6.6 billion by 2034 from US$ 2.9 billion in 2024, growing at a CAGR of 8.5% during the forecast period 2025 to 2034. In 2024, North America led the market, achieving over 44.8% share with a revenue of US$ 1.3 Billion.

    Increasing demand for effective preclinical research and drug development has driven significant growth in the animal model market. As the healthcare and pharmaceutical industries advance, the need for reliable models to simulate human diseases and test therapies has become more critical. Animal models play a vital role in understanding the pathophysiology of diseases, drug toxicity, and efficacy testing.

    Recent trends show an increasing preference for genetically modified and humanized animal models, which offer more accurate representations of human diseases. These models contribute to advancements in oncology, immunology, and genetics, among other fields. In May 2023, a research team from University Hospital Carl Gustav Carus successfully developed a humanized mouse model with a mutated gene that leads to congenital adrenal hyperplasia (CAH).

    This breakthrough is expected to offer a significant leap in understanding the disease and may lead to the development of new therapeutic approaches for treatment. The growing emphasis on precision medicine and personalized therapies further drives the demand for sophisticated animal models, presenting substantial opportunities for market expansion.

    Animal Model Market Size

    Key Takeaways

    • In 2023, the market for animal model generated a revenue of US$ 2.9 billion, with a CAGR of 8.5%, and is expected to reach US$ 6.6 billion by the year 2033.
    • The animal type segment is divided into mice, rat, guinea pigs, and others, with mice taking the lead in 2023 with a market share of 54.3%.
    • Considering application, the market is divided into cancer, immunological disease, infectious disease, and others. Among these, cancer held a significant share of 52.7%.
    • Furthermore, concerning the end-user segment, the market is segregated into pharmaceutical & biotechnology companies, academic research institute, and contract research organization. The pharmaceutical & biotechnology companies sector stands out as the dominant player, holding the largest revenue share of 57.6% in the animal model market.
    • North America led the market by securing a market share of 44.8% in 2023.

    Animal Type Analysis

    The mice segment led in 2023, claiming a market share of 54.3% owing to the increasing demand for genetically modified mouse models in research. Mice are widely used in preclinical research for their similarities to human biology, their short lifespan, and their ability to replicate various diseases. These factors make mice an essential animal model for studying human diseases, drug testing, and understanding disease mechanisms.

    The growth of biotechnology and pharmaceutical research, particularly in areas such as cancer and immunological disease studies, is expected to further drive the demand for mice in laboratory settings. Additionally, advancements in genetic manipulation and their role in personalized medicine are likely to fuel the growth of the mice segment in the coming years.

    Application Analysis

    The cancer held a significant share of 52.7% due to the increasing prevalence of cancer globally and the demand for effective treatments. Animal models play a crucial role in cancer research, as they are used to study tumor development, metastasis, and response to therapies.

    The rising incidence of various cancers and the need for novel therapies is expected to push demand for animal models that can simulate human cancers accurately. The growth of personalized medicine and targeted therapies is projected to further bolster the need for cancer-related animal models, making them vital tools for preclinical drug development and testing.

    End-User Analysis

    The pharmaceutical & biotechnology companies segment had a tremendous growth rate, with a revenue share of 57.6% owing to the increasing investment in drug discovery and development. Pharmaceutical and biotechnology companies rely heavily on animal models for preclinical testing to ensure the safety and efficacy of new drugs before human trials. As these companies focus on developing treatments for chronic diseases, cancer, and genetic disorders, the demand for animal models is projected to rise.

    Additionally, the expansion of research in areas like personalized medicine and gene editing technologies is likely to increase the reliance on animal models for innovation in drug development. This segment is expected to continue growing as pharmaceutical and biotechnology companies seek better solutions for drug testing and disease research.

    Animal Model Market Share

    Key Market Segments

    By Animal Type

    • Mice
    • Rat
    • Guinea Pigs
    • Others

    By Application

    • Cancer
    • Immunological Disease
    • Infectious Disease
    • Others

    By End-user

    • Pharmaceutical & Biotechnology Companies
    • Academic Research Institute
    • Contract Research Organization

    Drivers

    Increasing Demand for Personalized Medicine is Driving the Market
    The growing focus on precision medicine is significantly driving the need for genetically tailored models in drug development and disease research. Pharmaceutical companies and academic institutions are leveraging advanced models, such as CRISPR-engineered mice, to study patient-specific treatments. These models provide more accurate representations of human biology, which is crucial in developing targeted therapies for conditions such as cancer and genetic disorders.

    As biologics and gene therapies increasingly require sophisticated preclinical testing, demand for genetically engineered models continues to rise. The shift towards more personalized treatments amplifies the need for highly specific animal models that can better predict human responses, ensuring sustained growth in this market.

    Restraints

    High Costs and Ethical Concerns are Restraining the Market
    The high cost of maintaining genetically modified colonies and complying with stringent animal welfare regulations significantly restricts market expansion. A single transgenic mouse model can cost upwards of US$5,000, with additional ongoing costs for housing, care, and management. Ethical guidelines, particularly in the EU and other regions, limit the types of procedures that can be conducted, which slows research progress in those areas.

    Smaller biotech firms often face financial constraints that make it difficult to afford advanced models, forcing them to rely on less expensive alternatives, such as in silico simulations. While these ethical measures are necessary for animal welfare, they contribute to the high costs of research and can hinder innovation, particularly for smaller research entities and academic institutions.

    Opportunities

    Advancements in 3D Bioprinting are Creating Growth Opportunities
    The development of 3D bioprinting technology has opened up exciting new opportunities in the creation of hybrid models that reduce the reliance on live animal subjects. This technology allows researchers to print tissues that mimic the biological structures of humans and animals, providing a more ethical and cost-effective alternative to traditional animal models. Companies are increasingly developing printed tissue models that are used for drug toxicity testing and other research applications.

    In 2023, the FDA approved the use of bioprinted liver models for preclinical trials, signaling growing regulatory acceptance. This innovation has the potential to greatly accelerate the pace of drug development while reducing the need for live animal testing, especially in fields like oncology and neurology, where new models are in high demand.

    Impact of Macroeconomic / Geopolitical Factors

    Economic instability and geopolitical tensions are influencing the lab animal models market, with inflation raising operational costs for breeding facilities, leading to higher prices for genetically modified strains. Trade restrictions, especially between the US and China, have disrupted the supply of essential raw materials, including genetically modified strains, which has delayed research progress. On the other hand, governments in various regions are investing in the development of alternative animal models, as demonstrated by funding for the Horizon Europe program, which supports the creation of non-animal testing alternatives.

    Additionally, geopolitical tensions have spurred investments in local production capabilities, reducing reliance on imports and improving market accessibility. Despite these challenges, the market remains resilient, with ongoing advancements in research technology and an increasing focus on personalized medicine driving long-term growth.

    Latest Trends

    Rising Adoption of Humanized Mouse Models is a Recent Market Trend
    Humanized mouse models, which involve engrafting immunodeficient mice with human cells or tissues, are becoming more prevalent in research, especially in oncology and infectious disease studies. These models offer a more accurate representation of human responses to diseases and treatments, making them particularly valuable in drug development and vaccine testing.

    The demand for these models has increased significantly as drug development becomes more targeted and personalized. With researchers focusing more on human-specific disease pathways, these humanized models are helping improve the accuracy of preclinical trials, thus driving innovation. As the need for more precise models continues to rise, these systems are expected to play a larger role in shaping future therapies and treatments.

    Regional Analysis

    North America is leading the Animal Model Market

    North America dominated the market with the highest revenue share of 44.8% owing to increased biomedical research funding, rising demand for personalized medicine, and advancements in genetic engineering technologies. The National Institutes of Health (NIH) allocated US$2.5 billion for preclinical research using animal subjects in 2024, supporting various therapeutic areas, including neurodegenerative diseases.

    Additionally, the USDA documented a 25% increase in primate imports for research purposes in 2024, reflecting the growing need for translational models. These developments, combined with strong academic-industry collaborations, solidified North America’s position as the dominant market for research models.

    The Asia Pacific region is expected to experience the highest CAGR during the forecast period

    Asia Pacific is expected to grow with the fastest CAGR owing to expanding pharmaceutical R&D investments, government-backed biomedical initiatives, and increasing outsourcing of preclinical studies. China’s National Medical Products Administration (NMPA) approved a significant rise in drug trials using animal subjects in 2024, signaling accelerated domestic research activity.

    Japan’s Ministry of Health, Labour and Welfare allocated US$800 million for regenerative medicine studies in 2024, alongside US$150 million to establish new animal research facilities. Australia’s National Health and Medical Research Council (NHMRC) funded a notable increase in projects requiring preclinical models in 2024 compared to 2022. These strategic developments, coupled with regional cost advantages in research services, position Asia Pacific for substantial market expansion in the coming years.

    Animal Model Market Region

    Key Regions and Countries

    North America

    • US
    • Canada

    Europe

    • Germany
    • France
    • The UK
    • Spain
    • Italy
    • Russia
    • Netherland
    • Rest of Europe

    Asia Pacific

    • China
    • Japan
    • South Korea
    • India
    • Australia
    • New Zealand
    • Singapore
    • Thailand
    • Vietnam
    • Rest of APAC

    Latin America

    • Brazil
    • Mexico
    • Rest of Latin America

    Middle East & Africa

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA

    Key Players Analysis

    Key players in the animal model market drive growth by investing in product innovation, forming strategic partnerships, and expanding their global presence. They focus on developing advanced animal models that closely mimic human diseases, enhancing the predictability of research outcomes. Collaborations with academic institutions and pharmaceutical companies facilitate the integration of cutting-edge technologies, broadening market reach. Additionally, targeting emerging markets with increasing research activities presents significant growth opportunities.​

    GenOway, headquartered in Lyon, France, specializes in the development and production of genetically modified animal models for research purposes. The company offers a wide range of services, including the creation of custom models and the distribution of ready-to-use models, catering to various research applications. GenOway emphasizes technological advancements and quality, aiming to provide researchers with reliable tools for drug discovery and disease modeling. Through strategic collaborations and a global distribution network, GenOway continues to expand its influence in the animal model market.​

    Top Key Players

    • The Jackson Laboratory
    • Nimmune Biopharma
    • Inotiv
    • Harbour BioMed
    • Crown Bioscience
    • Charles River Laboratories
    • Biosplice Therapeutics
    • BIOCYTOGEN

    Recent Developments

    • In September 2024, Nimmune Biopharma formed a strategic alliance with BioTherapeutics, Inc. to fast-track the development of innovative medical products. This partnership grants Nimmune access to BioTherapeutics’ advanced preclinical and regulatory services, enhancing the development of both animal and computational models aimed at advancing precision immunology therapies.
    • In June 2024, Biosplice Therapeutics, Inc. entered into a collaboration with Novo Nordisk to jointly create novel drug candidates for diabetes treatment. This partnership aims to leverage both companies’ expertise in drug development to accelerate the creation of effective treatments for diabetes.

    Report Scope

    Report Features Description
    Market Value (2024) US$ 2.9 billion
    Forecast Revenue (2034) US$ 6.6 billion
    CAGR (2025-2034) 8.5%
    Base Year for Estimation 2024
    Historic Period 2020-2023
    Forecast Period 2025-2034
    Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments
    Segments Covered By Animal Type (Mice, Rat, Guinea Pigs, and Others), By Application (Cancer, Immunological Disease, Infectious Disease, and Others), By End-user (Pharmaceutical & Biotechnology Companies, Academic Research Institute, and Contract Research Organization)
    Regional Analysis North America – US, Canada; Europe – Germany, France, The UK, Spain, Italy, Russia, Netherlands, Rest of Europe; Asia Pacific – China, Japan, South Korea, India, Australia, New Zealand, Singapore, Thailand, Vietnam, Rest of APAC; Latin America – Brazil, Mexico, Rest of Latin America; Middle East & Africa – South Africa, Saudi Arabia, UAE, Rest of MEA
    Competitive Landscape The Jackson Laboratory, Nimmune Biopharma, Inotiv, Harbour BioMed, Crown Bioscience, Charles River Laboratories, Biosplice Therapeutics, and BIOCYTOGEN.
    Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements.
    Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)
    Animal Model Market
    Animal Model Market
    Published date: Animal Model Market
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    • The Jackson Laboratory
    • Nimmune Biopharma
    • Inotiv
    • Harbour BioMed
    • Crown Bioscience
    • Charles River Laboratories
    • Biosplice Therapeutics
    • BIOCYTOGEN
  • settingsSettings

Related Reports

  • Europe Dalbavancin Market
  • Topical Androgen Receptor Inhibitors Market
  • Drug-Induced Cardiotoxicity Market
  • Radiotherapy-Induced Nausea and Vomiting Treatment Market
  • Triglycerides Testing Reagents Market
  • Bacterial Vaginosis Rx Drug Market
  • Legal Cannabis Market
  • Sports Medicine Market
  • Generic Drugs Market
  • Smart Bandages Market

Our Clients

  • Our Clients
Inquiry Before Buying

Animal Model Market
  • 146082
  • Animal Model Market
    • ★★★★★
      ★★★★★
    • (142)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 874 1545 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
Secured Payment Options
Secured Payment Options

© 2025 Market.Us. All Rights Reserved.